Skip to main content
ABVC BIOPHARMA, INC. logo

ABVC BIOPHARMA, INC. — Investor Relations & Filings

Ticker · ABVC ISIN · US00091F1066 US Manufacturing
Open in API
Filings indexed 780 across all filing types
Latest filing 2015-04-16 Interim / Quarterly Rep…
Country US United States of America
Listing US ABVC

About ABVC BIOPHARMA, INC.

https://abvcpharma.com/

ABVC BioPharma, Inc. is a clinical-stage biopharmaceutical company that develops and commercializes drugs and medical devices to address unmet medical needs. The company focuses on advancing a pipeline of botanical, plant-based pharmaceuticals and medical technologies sourced from research institutions. Its therapeutic areas of focus include oncology, ophthalmology, and central nervous system disorders such as major depressive disorder (MDD) and adult attention-deficit/hyperactivity disorder (ADHD). Key products in development include Vitargus®, a biodegradable vitreous substitute for eye surgery, and botanical drug candidates for MDD and ADHD. Additionally, its subsidiary, BioKey, Inc., offers contract development and manufacturing services for nutritional and pharmaceutical products.

Recent filings

Filing Released Lang Actions
Interim / Quarterly Report 2013
Interim / Quarterly Report Q1 2013
2015-04-16 English
Annual Report 2012
Annual Report FY 2012
2015-04-15 English
Regulatory Filings 2014
Regulatory Filings
2014-11-20 English
Regulatory Filings 2014
Regulatory Filings Classification · 100% confidence The document is a letter from the CEO of Ecology Coatings, Inc. addressed to the SEC Division of Corporate Finance. It references a Form 8-K filing dated October 31, 2014, and acknowledges responsibility for the accuracy of that filing. The content is primarily a certification or attestation related to a regulatory filing (Form 8-K). The document length is short (1067 characters), and it does not contain financial data or detailed report content. According to the Certification Rule, such officer certifications should be classified as Regulatory Filings (RNS), not as the report itself. Therefore, the appropriate classification is Regulatory Filings (RNS).
2014-11-19 English
ECOC 8KA
Regulatory Filings Classification · 95% confidence The document is a Form 8-K/A filed with the SEC, specifically a Current Report that amends a previous 8-K. The content focuses on a change in the company's certifying accountant, detailing the engagement of a new CPA firm and confirming no disagreements or reportable events related to accounting principles or audit opinions. There are no financial statements or substantive financial data presented. The document is relatively short (3105 characters) and serves as a regulatory disclosure about management/accounting changes rather than a full audit report or annual report. Therefore, it fits best under Regulatory Filings (RNS) as it is a compliance disclosure that does not constitute a full audit report or financial report.
2014-11-06 English
Regulatory Filings 2014
Regulatory Filings
2014-11-05 English

Browse filings by year

25 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.